Tables 1–3 show the top 10 drugs for the year July 2016 – June 2017. The figures are based on PBS and RPBS prescriptions from the date of supply. This year's figures include prescriptions under the co-payment (non-subsidised).
The capture of below co-payment data probably explains why drugs such as amoxicillin, which were previously absent, now appear in the top 10 drugs by prescription count. Drugs for hepatitis C continue to dominate the top 10 most expensive drugs.
* DDD/thousand population/day is a more useful measure of drug utilisation than prescription counts. It shows how many people in every thousand Australians are taking the standard dose of a drug every day. DDD includes use in combination products. The calculation is based on ABS 3101.0 – Australian Demographic Statistics for December 2016 (as at March 2017).
† DDDs in combination products are accounted for in constituent drugs
‡ The World Health Organization has not allocated a DDD for this drug
Reasonable care is taken to provide accurate information at the time of creation. This information is not intended as a substitute for medical advice and should not be exclusively relied on to manage or diagnose a medical condition. NPS MedicineWise disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer. This website uses cookies. Read our privacy policy.